Literature DB >> 16160921

Driving after cerebral ischemia--a driving simulator investigation.

Sylvia Kotterba1, Walter Widdig, Stefan Brylak, Maritta Orth.   

Abstract

UNLABELLED: Stroke patients with relevant deficits are not allowed to drive. This study tended to assess driving abilities in an early stage after cerebral ischemia with a driving simulator.
METHODS: 32 patients (aged 54.9 +/- 14.8 years) with acute ischemia in the middle cerebral artery (MCA) (n = 24) and in the vertebral artery (VA) (n = 8) were investigated with reaction tests and a driving simulator. Controls were 12 healthy volunteers (aged 50.0 +/- 13.9 years).
RESULTS: Compared to controls, the accident rate was increased only in patients with MCA-ischemia (2.9 +/- 3.6 vs. 1.3 +/- 1.4, p < 0.05). These patients also had poorer results in the driving simulator (p < 0.05) than patients with VA-ischemia. Driving simulator performance and neuropsychological test results did not correlate.
CONCLUSION: All patients had only mild deficits and stated themselves able to drive. We could demonstrate the need to focus on driving skills especially in patients with MCA-infarctions. The driving simulator assesses various physical and neuropsychological functions influencing driving. It may especially be used for expert opinions regarding driving licence. It can also serve as a pre-driver evaluation before on road driving tests.

Entities:  

Mesh:

Year:  2005        PMID: 16160921     DOI: 10.1007/s10354-005-0191-3

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  2 in total

Review 1.  Rehabilitation for improving automobile driving after stroke.

Authors:  Stacey George; Maria Crotty; Isabelle Gelinas; Hannes Devos
Journal:  Cochrane Database Syst Rev       Date:  2014-02-25

2.  Assessing Cognitive Ability and Simulator-Based Driving Performance in Poststroke Adults.

Authors:  Alison Blane; Hoe C Lee; Torbjörn Falkmer; Tania Dukic Willstrand
Journal:  Behav Neurol       Date:  2017-05-07       Impact factor: 3.342

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.